Search Within

Martee L Hensley

Formats
  1. Journal Article (174)
  2. Meeting Abstract (106)
  3. Book Section (7)
  4. Correspondence (1)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Department of Medicine (290)
  2. GDMT, Medicine (290)
  3. Gynecologic Medicine Service (290)
  4. Gynecology Disease Management Team (290)
  5. Solid Tumor Oncology Division (290)
  6. Surgery (129)

More Groups

People
  1. Carol Aghajanian (94)
  2. Paul Sabbatini (81)
  3. Robert Soslow (63)
  4. David Spriggs (55)
  5. Mario Leitao (53)
  6. Richard Barakat (53)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (11)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (80)
  2. Gynecologic Oncology (73)
  3. International Journal of Gynecological Cancer (22)
  4. Modern Pathology (18)
  5. Clinical Cancer Research (15)
  6. Laboratory Investigation (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Elsevier Inc. (81)
  3. Lippincott Williams & Wilkins (33)
  4. Nature Research (18)
  5. American Association for Cancer Research (17)
  6. Nature Publishing Group (13)

More Publishers

Results (290)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic landscape of uterine sarcomas defined through prospective clinical sequencing
    Journal Article

    Hensley, M. L.; Chavan, S. S.; Solit, D. B.; Murali, R.; Soslow, R.; Chiang, S.; Jungbluth, A. A.; Bandlamudi, C.; Srinivasan, P.; Tap, W. D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Frequency of molecular alterations using a targeted RNA sequencing approach in uterine mesenchymal tumors
    Meeting Abstract

    Maldonado, L.; Momeni Boroujeni, A.; Benayed, R.; Hensley, M.; Ladanyi, M.; Park, K.; Soslow, R.; Chiang, S.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • High NTRK3 expression in high-grade endometrial stromal sarcomas with BCOR abnormalities
    Meeting Abstract

    Momeni Boroujeni, A.; Benayed, R.; Hensley, M.; Antonescu, C.; Ladanyi, M.; Chiang, S.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway
    Journal Article

    Rubinstein, M. M.; Hyman, D. M.; Caird, I.; Won, H.; Soldan, K.; Seier, K.; Iasonos, A.; Tew, W. P.; O’Cearbhaill, R. E.; Grisham, R. N.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study
    Journal Article

    Mai, P. L.; Huang, H. Q.; Wenzel, L. B.; Han, P. K.; Moser, R. P.; Rodriguez, G. C.; Boggess, J.; Rutherford, T. J.; Cohn, D. E.; Kauff, N. D.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • ESR1 hotspot mutations in endometrial stromal sacromas may confer hormonal resistance
    Meeting Abstract

    Dessources, K.; Da Cruz Paula, A.; Lee, S.; Zou, Y.; Soslow, R. A.; Hensley, M. L.; Weigelt, B.; Chiang, S.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • DNA damage response pathway alterations and clinical outcome in leiomyosarcoma
    Meeting Abstract

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Qin, L. X.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial
    Meeting Abstract

    Powell, M. A.; Filiaci, V. L.; Hensley, M. L.; Huang, H. Q.; Moore, K. N.; Tewari, K. S.; Copeland, L. J.; Secord, A. A.; Mutch, D. G.; Santin, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Secondary surgical resection for patients with recurrent uterine leiomyosarcoma
    Journal Article

    Cybulska, P.; Sioulas, V.; Orfanelli, T.; Zivanovic, O.; Mueller, J. J.; Broach, V. A.; Long Roche, K. C.; Sonoda, Y.; Hensley, M. L.; O'Cearbhaill, R. E.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma
    Journal Article

    Patel, S.; von Mehren, M.; Reed, D. R.; Kaiser, P.; Charlson, J.; Ryan, C. W.; Rushing, D.; Livingston, M.; Singh, A.; Seth, R.; more...
    Cancer (2019)

    Fulltext@MSK | Save